These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 22930243)
1. Recommendations for including multiple symptoms as endpoints in cancer clinical trials: a report from the ASCPRO (Assessing the Symptoms of Cancer Using Patient-Reported Outcomes) Multisymptom Task Force. Cleeland CS; Sloan JA; Cella D; Chen C; Dueck AC; Janjan NA; Liepa AM; Mallick R; O'Mara A; Pearson JD; Torigoe Y; Wang XS; Williams LA; Woodruff JF; Cancer; 2013 Jan; 119(2):411-20. PubMed ID: 22930243 [TBL] [Abstract][Full Text] [Related]
2. Assessing the Symptoms of Cancer Using Patient-Reported Outcomes (ASCPRO): searching for standards. Cleeland CS; Sloan JA; J Pain Symptom Manage; 2010 Jun; 39(6):1077-85. PubMed ID: 20538189 [TBL] [Abstract][Full Text] [Related]
3. Symptom burden: multiple symptoms and their impact as patient-reported outcomes. Cleeland CS J Natl Cancer Inst Monogr; 2007; (37):16-21. PubMed ID: 17951226 [TBL] [Abstract][Full Text] [Related]
4. Health-related quality of life in early breast cancer. Groenvold M Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024 [TBL] [Abstract][Full Text] [Related]
5. How a well-grounded minimal important difference can enhance transparency of labelling claims and improve interpretation of a patient reported outcome measure. Brozek JL; Guyatt GH; Schünemann HJ Health Qual Life Outcomes; 2006 Sep; 4():69. PubMed ID: 17005037 [TBL] [Abstract][Full Text] [Related]
6. Family pediatrics: report of the Task Force on the Family. Schor EL; Pediatrics; 2003 Jun; 111(6 Pt 2):1541-71. PubMed ID: 12777595 [TBL] [Abstract][Full Text] [Related]
7. Assessment of patient-reported outcomes in clinical trials: the example of health-related quality of life. Wiklund I Fundam Clin Pharmacol; 2004 Jun; 18(3):351-63. PubMed ID: 15147288 [TBL] [Abstract][Full Text] [Related]
8. Standardizing patient-reported outcomes assessment in cancer clinical trials: a patient-reported outcomes measurement information system initiative. Garcia SF; Cella D; Clauser SB; Flynn KE; Lad T; Lai JS; Reeve BB; Smith AW; Stone AA; Weinfurt K J Clin Oncol; 2007 Nov; 25(32):5106-12. PubMed ID: 17991929 [TBL] [Abstract][Full Text] [Related]
9. Issues affecting the selection of participation measurement in outcomes research and clinical trials. Whiteneck GG Arch Phys Med Rehabil; 2010 Sep; 91(9 Suppl):S54-9. PubMed ID: 20801281 [TBL] [Abstract][Full Text] [Related]
11. Measuring treatment impact: a review of patient-reported outcomes and other efficacy endpoints in approved product labels. Willke RJ; Burke LB; Erickson P Control Clin Trials; 2004 Dec; 25(6):535-52. PubMed ID: 15588741 [TBL] [Abstract][Full Text] [Related]
12. Recommendations for assessing patient-reported outcomes and health-related quality of life in patients with urticaria: a GA(2) LEN taskforce position paper. Baiardini I; Braido F; Bindslev-Jensen C; Bousquet PJ; Brzoza Z; Canonica GW; Compalati E; Fiocchi A; Fokkens W; Gerth van Wijk R; Giménez-Arnau A; Godse K; Grattan C; Grob JJ; La Grutta S; Kalogeromitros D; Kocatürk E; Lombardi C; Mota-Pinto A; Ridolo E; Saini SS; Sanchez-Borges M; Senna GE; Terreehorst I; Todo Bom A; Toubi E; Bousquet J; Zuberbier T; Maurer M Allergy; 2011 Jul; 66(7):840-4. PubMed ID: 21385184 [TBL] [Abstract][Full Text] [Related]
13. Outcome measures for palliative care research. Agar M; Luckett T Curr Opin Support Palliat Care; 2012 Dec; 6(4):500-7. PubMed ID: 23080308 [TBL] [Abstract][Full Text] [Related]
14. Outcomes research in cancer symptom management trials: the Radiation Therapy Oncology Group (RTOG) conceptual model. Bruner DW J Natl Cancer Inst Monogr; 2007; (37):12-5. PubMed ID: 17951225 [TBL] [Abstract][Full Text] [Related]
15. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder. Klassen AF; Miller A; Fine S Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087 [TBL] [Abstract][Full Text] [Related]
17. Minimal disease activity for rheumatoid arthritis: a preliminary definition. Wells GA; Boers M; Shea B; Brooks PM; Simon LS; Strand CV; Aletaha D; Anderson JJ; Bombardier C; Dougados M; Emery P; Felson DT; Fransen J; Furst DE; Hazes JM; Johnson KR; Kirwan JR; Landewé RB; Lassere MN; Michaud K; Suarez-Almazor M; Silman AJ; Smolen JS; Van der Heijde DM; van Riel PL; Wolfe F; Tugwell PS J Rheumatol; 2005 Oct; 32(10):2016-24. PubMed ID: 16206362 [TBL] [Abstract][Full Text] [Related]
18. Multinational trials-recommendations on the translations required, approaches to using the same language in different countries, and the approaches to support pooling the data: the ISPOR Patient-Reported Outcomes Translation and Linguistic Validation Good Research Practices Task Force report. Wild D; Eremenco S; Mear I; Martin M; Houchin C; Gawlicki M; Hareendran A; Wiklund I; Chong LY; von Maltzahn R; Cohen L; Molsen E Value Health; 2009 Jun; 12(4):430-40. PubMed ID: 19138309 [TBL] [Abstract][Full Text] [Related]
19. Current status of patient-reported outcomes in industry-sponsored oncology clinical trials and product labels. Gondek K; Sagnier PP; Gilchrist K; Woolley JM J Clin Oncol; 2007 Nov; 25(32):5087-93. PubMed ID: 17991926 [TBL] [Abstract][Full Text] [Related]
20. Recommendations for assessing patient-reported outcomes and health-related quality of life in clinical trials on allergy: a GA(2)LEN taskforce position paper. Baiardini I; Bousquet PJ; Brzoza Z; Canonica GW; Compalati E; Fiocchi A; Fokkens W; van Wijk RG; La Grutta S; Lombardi C; Maurer M; Pinto AM; Ridolo E; Senna GE; Terreehorst I; Bom AT; Bousquet J; Zuberbier T; Braido F; Allergy; 2010 Mar; 65(3):290-5. PubMed ID: 19930232 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]